{"title":"Vaccines","description":null,"products":[{"product_id":"vaccines-book-paige-v-polinsky-9781728448725","title":"A Vaccines","description":"\u003cp\u003eVaccines have been used to safely introduce people's bodies to diseases for centuries, and they save millions of lives each year. By giving people a weakened or dead version of a disease, a vaccine allows the body to develop antibodies which recognize and fight the disease later on.\u003cbr\u003e \u003cbr\u003e \u003cbr\u003e \u003cbr\u003e Early vaccinations used dry scabs from smallpox to promote smallpox immunity. Doctors and scientists across nations took and improved the method, developing vaccines for health crises from whooping cough to polio to COVID-19. This graphic history features famous cases and current challenges, including the time frame for creating a new vaccine.\u003c\/p\u003e","brand":"WoB","offers":[{"title":"US \/ GOOD \/ SBYB","offer_id":50042464043281,"sku":"CIN1728448727G","price":0.0,"currency_code":"GBP","in_stock":true},{"title":"US \/ VERY_GOOD \/ SBYB","offer_id":50388717011217,"sku":"CIN1728448727VG","price":0.0,"currency_code":"GBP","in_stock":false},{"title":"US \/ WELL_READ \/ SBYB","offer_id":50399769690385,"sku":"CIN1728448727A","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/1728448727.jpg?v=1751183801"},{"product_id":"ranking-vaccines-book-institute-of-medicine-9780309255257","title":"Ranking Vaccines","description":"As a number of diseases emerge or reemerge thus stimulating new vaccine development opportunities to help prevent those diseases, it can be especially difficult for decision makers to know where to invest their limited resources. Therefore, it is increasingly important for decision makers to have the tools that can assist and inform their vaccine prioritization efforts. In this first phase report, the IOM offers a framework and proof of concept to account for various factors influencing vaccine prioritization-demographic, economic, health, scientific, business, programmatic, social, policy factors and public concerns. Ranking Vaccines: A Prioritization Framework describes a decision-support model and the blueprint of a software-called Strategic Multi-Attribute Ranking Tool for Vaccines or SMART Vaccines. SMART Vaccines should be of help to decision makers. SMART Vaccines Beta is not available for public use, but SMART Vaccines 1.0 is expected to be released at the end of the second phase of this study, when it will be fully operational and capable of guiding discussions about prioritizing the development and introduction of new vaccines.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ GARDNERS","offer_id":53247167463697,"sku":"NGR9780309255257","price":0.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9780309255257.jpg?v=1773443698"},{"product_id":"adverse-events-associated-with-childhood-vaccines-book-institute-of-medicine-9780309074964","title":"Adverse Events Associated with Childhood Vaccines","description":"Childhood immunization is one of the major public health measures of the 20th century and is now receiving special attention from the Clinton administration. At the same time, some parents and health professionals are questioning the safety of vaccines because of the occurrence of rare adverse events after immunization. This volume provides the most thorough literature review available about links between common childhood vaccines--tetanus, diphtheria, measles, mumps, polio, Haemophilus influenzae b, and hepatitis B--and specific types of disorders or death. The authors discuss approaches to evidence and causality and examine the consequences--neurologic and immunologic disorders and death--linked with immunization. Discussion also includes background information on the development of the vaccines and details about the case reports, clinical trials, and other evidence associating each vaccine with specific disorders. This comprehensive volume will be an important resource to anyone concerned about the immunization controversy: public health officials, pediatricians, attorneys, researchers, and parents.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":53247172509969,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ GARDNERS","offer_id":53247172870417,"sku":"NGR9780309074964","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9780309074964.jpg?v=1773443722"},{"product_id":"eliminating-the-public-health-problem-of-hepatitis-b-and-c-in-the-united-states-book-national-academies-of-sciences-9780309437998","title":"Eliminating the Public Health Problem of Hepatitis B and C in the United States","description":"Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of worlda (TM)s hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the first of two, examines the feasibility of hepatitis B and C elimination in the United States and identifies critical success factors. The phase two report will outline a strategy for meeting the elimination goals discussed in this report.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":53247176769809,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ GARDNERS","offer_id":53247177228561,"sku":"NGR9780309437998","price":0.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9780309437998.jpg?v=1773443815"},{"product_id":"immunization-safety-review-book-institute-of-medicine-9780309090865","title":"Immunization Safety Review","description":"Argues that the evidence favored rejection of a causal relationship between influenza vaccines and exacerbation of multiple sclerosis. This work also argues that the evidence about the effects of influenza vaccine is inadequate to accept or reject a causal relationship. It reviews theories on how influenza vaccine can damage the nervous system.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ GARDNERS","offer_id":53257746186513,"sku":"NGR9780309090865","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9780309090865.jpg?v=1773703075"},{"product_id":"immunization-safety-review-book-institute-of-medicine-9780309074476","title":"Immunization Safety Review","description":"Immunization is widely regarded as one of the most effective and beneficial tools for protecting the public's health. In the United States, immunization programs have resulted in the eradication of smallpox, the elimination of polio, and the control and near elimination of once-common, often debilitating and potentially life-threatening diseases, including measles, mumps, rubella, diphtheria, pertussis, tetanus, and Haemophilus influenza type b. Along with the benefits of widespread immunization, however, have come concerns about the safety of vaccines. No vaccine is perfectly safe or effective, and vaccines may lead to serious adverse effects in some instances. Furthermore, if a serious illness is observed after vaccination, it is often unclear whether that sequence is coincidental or causal, and it can be difficult to determine the true nature of the relationship, if any, between the vaccination and the illness. Ironically, the successes of vaccine coverage in the United States have made it more difficult for the public to weigh the benefits and complications of vaccines because the now-controlled diseases and their often-serious risks are no longer familiar. However, because vaccines are so widely used-and because state laws require that children be vaccinated before entering daycare and school, in part to protect others-it is essential that safety concerns be fully and carefully studied. Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism, the first of a series from the Institute of Medicine (IOM) Immunization Safety Review Committee, presents an assessment of the evidence regarding a hypothesized causal association between the measles-mumps-rubella (MMR) vaccine and autism, an assessment of the broader significance for society of the issues surrounding the MMR-autism hypothesis, and the committee's conclusions and recommendations based on those assessments.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":53257745662225,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ GARDNERS","offer_id":53257746120977,"sku":"NGR9780309074476","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9780309074476.jpg?v=1773703075"}],"url":"https:\/\/www.worldofbooks.com\/collections\/author-books-by-vaccines.oembed","provider":"World of Books ","version":"1.0","type":"link"}